GASTRODUODENAL BLEEDING IN PATIENTS WITH CARDIAC PATHOLOGY
Erosive and ulcerative gastroduodenal bleeding (GDB) in patients with cardiac pathology is threatening complication, in which the mortality rate ranges from 9,6 to 80%, reaching the highest numbers of patients of elderly and senile age. The need for acceptance of pathogenetic therapy, including antiplatelet agents, nonsteroidal anti-inflammatory drugs and anticoagulants of direct action greatly complicates the treatment of erosive and ulcerative GDB, which in itself is also a threat to the life of the patient. All this dictates the need for a rational treatment strategies for these patients to minimize the threat of the death of the patients from both the GDB and from heart disease. Designed by the authors of the algorithm treatment of different variants of the GDB allowed to reduce the mortality rate to 16,2%. Treatment of patients with this comorbidity requires a differentiated approach, depending on the nature and intensity of bleeding or the threat of its recurrence in the background of the need for pathogenetic therapy of the underlying disease.